Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Virtru | 2025 | Series D | $50.0M | Washington |
| Rhythm Pharmaceuticals | 2025 | Post Ipo Equity | $175.0M | Boston |
| Fastino | 2025 | Seed | Undisclosed | Palo Alto |
| Radiology Partners | 2025 | Debt Financing | $2.3B | El Segundo |
| Tempus | 2025 | Post Ipo Debt | $650.0M | Chicago |
| Foresight Data | 2025 | Seed | $5.5M | New York |
| Splice Bio | 2025 | Series B | $135.0M | Barcelona |
| Jomboy Media | 2025 | Undisclosed | Undisclosed | Bronx |
| Allay Therapeutics | 2025 | Series D | $57.5M | San Jose |
| Spyglass Pharma | 2025 | Series D | $75.0M | Aliso Viejo |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | Virtru | Series D | $50.0M | Washington, United States |
| 177 | Rhythm Pharmaceuticals | Post Ipo Equity | $175.0M | Boston, United States |
| 178 | Fastino | Seed | Undisclosed | Palo Alto, United States |
| 179 | Radiology Partners | Debt Financing | $2.3B | El Segundo, United States |
| 180 | Tempus | Post Ipo Debt | $650.0M | Chicago, United States |
| 181 | Foresight Data | Seed | $5.5M | New York, United States |
| 182 | Splice Bio | Series B | $135.0M | Barcelona, Spain |
| 183 | Jomboy Media | Undisclosed | Undisclosed | Bronx, United States |
| 184 | Allay Therapeutics | Series D | $57.5M | San Jose, United States |
| 185 | Spyglass Pharma | Series D | $75.0M | Aliso Viejo, United States |
Virtru provides data encryption for email and file sharing, enabling users to easily control access to their sensitive data.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Fastino enable developers everywhere to do more with AI.
Radiology Partners is a healthcare service company providing radiology services.
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Foresight Data provides a platform for data-driven private market investors, integrating all investment data and offering IT services.
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
Sports and culture media properties
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Spyglass Pharma provides medicine for ophthalmic diseases.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Bringing Driverless Mobility to European cities.
Datafold is a data company that specializes in AI-based agents and tools that automate complicated data sets.
Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.
Slash is a financial technology company that offers deposits, payments, virtual cards, and expense tracking.
Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.
Arkestro is a predictive procurement platform that utilizes AI, behavioral science, and machine learning to enhance procurement processes.
Orby AI is an AI platform designed to bring the auto-complete experience to everyday business users and automate all mundane tasks.
Forethought is a generative AI suite for customer support automation.
Bestow is a life insurance SaaS company that utilizes advanced technology and data solutions for the insurance sector.
Agree.com is an agreement platform that unifies e-signature, invoicing, and secure payment processing into one seamless workflow.
Glacier develops AI-powered robotic systems to automate the sorting of recyclable materials in waste management facilities.
Canopy offers a cloud-based Practice Management solution for Accounting professionals.
Aetherflux develops a novel design for space.
SafeRide Health is a healthcare technology platform developer that aims to simplify medical services.
New Enterprise Associates has invested in 461 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
New Enterprise Associates's top investment sectors include Artificial Intelligence (AI), Software, Medical, Biotechnology, Health Care. The firm invests across 55 different industry categories.
Among tracked funding rounds, Radiology Partners received $2.3B in a Debt Financing round. New Enterprise Associates's total known invested capital is $23.0B.
New Enterprise Associates's average investment size is $69.4M across its portfolio of 461 companies.
Recent New Enterprise Associates portfolio additions include Virtru, Rhythm Pharmaceuticals, Fastino, Radiology Partners, Tempus. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors